Why Spatial Omics Is Transitioning From ‘Maps’ to ‘Mechanisms’
High-resolution maps showed us where cells live; the next phase of spatial omics is about extracting those cells and uncovering the molecular conversations that shape outcomes.
High-resolution maps showed us where cells live; the next phase of spatial omics is about extracting those cells and uncovering the molecular conversations that shape outcomes.
Weill Cornell Medicine researchers report a whole-genome sequencing algorithm may identify more patients for PARP inhibitor cancer therapies than current commercial tests, according to a study in Communications Medicine.
The version 2.0 systems feature increased throughput, expanded assay flexibility, and the ability to run up to six unique assays per run.
Two studies show the advanced technique can identify chromosomal abnormalities missed by traditional genetic testing methods.
Read MoreStudies demonstrate artificial intelligence achieving 93% cancer diagnostic accuracy and enabling noninvasive tumor analysis through spinal fluid testing.
Read MoreThe collaboration combines SOPHiA’s DDM platform with Element’s AVITI sequencing systems to streamline genomic workflows for precision medicine research.
Read MoreResearchers identify critical flaws in Oxford Nanopore devices that could expose or alter genetic data without detection.
Read MoreThe new module enables one-step reverse transcription and amplification, removing cDNA prep and supporting applications in translational research, cell and gene therapy manufacturing, and diagnostic development.
Read MoreThe GeneSight test results led to faster initial remission and response in patients with major depressive disorder, with benefits persisting over six months.
Read MoreThe collaboration will focus on creating a cortisol biosensor for stress and metabolic health testing using luminescent biosensors and AI-guided interpretation.
Read MoreThe designation accelerates regulatory review for GeneDx’s ExomeDx and GenomeDx testing platforms designed to diagnose rare diseases.
Read MoreThe upgrade leverages technology by Ultima Genomics and processing at the Gene by Gene lab.
Read MoreThe collaboration combines Profluent’s generative AI platform with IDT’s enzyme engineering and genomics expertise to accelerate development of next-generation enzymes.
Read MoreA decade-long study shows lower rates of provider-initiated reanalysis among Hispanic, Asian, and Black patients compared with White patients.
Read MoreMulti-omics study reveals psychiatric comorbidities in bladder pain syndrome patients while demonstrating advantages in hematological malignancies and repeat expansion analysis.
Read MoreSPRQ-Nx chemistry for Revio and Vega platforms is designed to reduce sequencing expenses by up to 40% while adding multiomic capabilities.
Read MoreThe machine learning-powered platform analyzes gene expression data from biopsies to provide molecular scores for rejection probability and tissue injury.
Read MoreA novel reverse transcriptase is designed to offer a more complete view of the transcriptome by overcoming decades-old technical hurdles in sample preparation.
Read More